Ciofoaia, V.; Chen, W.; Tarek, B.W.; Gay, M.; Shivapurkar, N.; Smith, J.P.
The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial. Pharmaceutics 2024, 16, 611.
https://doi.org/10.3390/pharmaceutics16050611
AMA Style
Ciofoaia V, Chen W, Tarek BW, Gay M, Shivapurkar N, Smith JP.
The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial. Pharmaceutics. 2024; 16(5):611.
https://doi.org/10.3390/pharmaceutics16050611
Chicago/Turabian Style
Ciofoaia, Victor, Wenqiang Chen, Bakain W. Tarek, Martha Gay, Narayan Shivapurkar, and Jill P. Smith.
2024. "The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial" Pharmaceutics 16, no. 5: 611.
https://doi.org/10.3390/pharmaceutics16050611
APA Style
Ciofoaia, V., Chen, W., Tarek, B. W., Gay, M., Shivapurkar, N., & Smith, J. P.
(2024). The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial. Pharmaceutics, 16(5), 611.
https://doi.org/10.3390/pharmaceutics16050611